Sherif Abou Elela
Sherif Abou Elela aims in his laboratory at understanding the basic mechanism that controls the synthesis and stability of RNA in eukaryotic cells in order to understand how genes are regulated. The work of this research team will impact not only our understanding of how genes are regulated but will also lead to the development of new tools for the regulation of gene expression. He is a Member of the oncology group of the centre de recherché clinique and the RNA group. He is also the Director of Sherbrooke Laboratory of functional genomics, the scientific director of Genome Quebec RNomics platform, and the Coordinator of the RiboClub. The RNomics platform was created by Genome Quebec as part of Sherbrooke laboratory of functional genomics. The platform offers academic and clinical researches as well as national and international industry, the unique opportunity to profile RNA expression and splicing pattern in relation to disease or phenotype of interest. The current emphasis is now on identifying novel markers for cancer but analysis of other disease can be easily envisioned. Due to the unique aspect and novelty of the technology developed in Abou Elela Laboratory and used by the RNomics platform, the Université de Sherbrooke is occupying a unique position in the field of RNA biology and the application of RNA tools for disease diagnostics and therapy. Genome Canada and Genome Quebec have invested more than 16 millions $ in the work of Abou Elela and made his findings available to other scientists through the RNomics Patform. Recently Prof. Abou Elela was named Chercheur National by the Fonds de la recherche en santé du Quebec (FRSQ).
Biography Updated on 1 November 2009